enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
Portfolio Pulse from
enVVeno Medical Corporation has submitted a PMA application to the FDA for approval to market the VenoValve in the US. Four out of five modules of the application have been approved. The company will present pivotal trial data at the VEITH Symposium.
November 19, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
enVVeno Medical has submitted a PMA application to the FDA for the VenoValve, with four out of five modules approved. This is a significant step towards US market entry.
The submission of the PMA application and the approval of four modules by the FDA is a positive development for enVVeno Medical, indicating progress towards potential market entry in the US. This could lead to increased investor confidence and a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100